BioPharm News

Feb 11, 2016
Vaccine R&D has grown exponentially in recent years, spurred by ethical and medical needs to combat lethal infectious outbreaks and increased funding from public and private agencies and organizations.
Feb 11, 2016
By BioPharm International Editors
GRAM completed a fourth FDA inspection of its parenteral manufacturing facility with no Form 483 observation issues.
Feb 10, 2016
By BioPharm International Editors
Metrohm USA awards the 2016 Young Chemist Award to PhD candidate developing wearable sensors that can non-invasively monitor physiologically relevant chemicals.
Feb 10, 2016
There was scant praise from the medical community for the eighth and final budget plan from the Obama administration.
Feb 09, 2016
Researchers describe a new method to compare the higher-order structure of a reference biologic with its proposed biosimilar product candidates.
Feb 09, 2016
By BioPharm International Editors
The agency prepares a plan to implement new packaging safety features.
Feb 09, 2016
By BioPharm International Editors
Pfizer names executive leadership team for combined organization upon close of proposed Allergan transaction.
Feb 08, 2016
By BioPharm International Editors
Barvarian Nordic, Evaxion Biotech, and the Technical University of Denmark announced plans to collaborate on the development of a vaccine for MRSA.
Feb 08, 2016
By BioPharm International Editors
FDA staff said Celltrion’s biosimilar form of infliximab is highly similar to Remicade.
Feb 08, 2016
By BioPharm International Editors
FDA granted Immunomedics breakthrough therapy designation for the company’s investigational antibody drug conjugate for treatment of triple negative breast cancer.
lorem ipsum